BBLG
BBLG
NASDAQ · Biotechnology

Bone Biologics Corp

$1.11
0.00 (-0.43%)
As of Mar 29, 11:05 PM ET ·
Financial Highlights (FY 2025)
Revenue
842.6K
Net Income
53.5K
Gross Margin
60.6%
Profit Margin
6.3%
Rev Growth
+2.0%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 60.6% 60.6% 60.6%
Operating Margin 6.7% 7.0% 6.4%
Profit Margin 6.3% 5.3% 5.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 842.6K 775.9K 707.6K
Gross Profit 510.4K 469.9K 428.6K
Operating Income 56.1K 53.9K 45.6K
Net Income 53.5K 41.0K 38.8K
Gross Margin 60.6% 60.6% 60.6%
Operating Margin 6.7% 7.0% 6.4%
Profit Margin 6.3% 5.3% 5.5%
Rev Growth +2.0% +16.5% +21.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 181.7K 202.0K 207.8K
Total Equity 1.11M 952.9K 1.08M
D/E Ratio 0.16 0.21 0.19
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 84.6K 70.9K 63.0K
Free Cash Flow 39.3K 30.9K 34.5K